Johnson & Johnson Janssen COVID-19 Vaccine from Japan
Janssen single-dose adenovirus type 26 COVID-19 vaccine for adults. Its immunological profile and retail packaging fit HTS 3002.15.00.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Single-dose only; wastage minimization strategies
• 2-8°C multi-month stability; emergency use authorizations
• Vector shedding studies for containment